Zobrazeno 1 - 10
of 134
pro vyhledávání: '"H. Haddada"'
Autor:
H. Haddada, M. A. Abina, Françoise Pflumio, William Vainchenker, Najet Debili, Jean-Luc Villeval, Catherine Lacout, Françoise Wendling, M. Tulliez
Publikováno v:
Gene therapy. 5(4)
Adenoviral vectors may be useful tools to deliver a cytokine in vivo. A single intravenous injection of an adenovirus vector containing the human thrombopoietin (TPO) cDNA (AdRSVhuTPO) was able to induce a thrombocytosis for more than 6 weeks in SCID
Autor:
A, Morel, A, de La Coste, N, Fernandez, A, Berson, M, Kaybanda, T, Molina, P, Briand, H, Haddada, J G, Guillet, B, Antoine, M, Viguier, A, Kahn
Publikováno v:
Cancer gene therapy. 5(2)
The use of genetically modified tumor cells as vaccines has been successful in numerous animal models of grafted syngenic tumors and has provided the groundwork for many clinical trials of gene therapy in cancer patients. To investigate the real effi
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 158(7)
Regression of P815 tumors established on naive syngeneic mice can be obtained by the intratumoral injection of a single dose of an adenoviral vector expressing the IL-2 gene (Ad.IL2). Injection triggers local IL-2 production for at least 10 days. We
Publikováno v:
Gene therapy. 3(3)
Numerous studies have shown that the expression of immuno-stimulatory genes in tumor cells can result in the development of antitumoral immunity resulting in the rejection of the tumor cells. We show here that the simple integration and expression of
Publikováno v:
Leukemia. 10(1)
As a first step to evaluate the possibility of gene therapy using adenoviral vectors in hematological malignancies in vivo, we tested the efficacy of gene transfer by a recombinant adenovirus in cell lines and fresh cells from various hematological n
Publikováno v:
Gene therapy. 2(4)
The immune response against cells infected by gene therapy vectors may be a major hindrance for gene therapy, destroying infected cells thus limiting the length of exogene expression and quickly eliminating infected cells on repeat administration. Ad
Publikováno v:
Bulletin du cancer. 82(3)
Autor:
L, Cordier, M T, Duffour, J C, Sabourin, M G, Lee, J, Cabannes, T, Ragot, M, Perricaudet, H, Haddada
Publikováno v:
Gene therapy. 2(1)
Direct introduction of exogenous genes into pre-existent tumors could provide an effective therapeutic approach for treatment of localized tumors. In this report we show that direct intratumoral delivery in animals of a replication-deficient adenovir
Publikováno v:
Current topics in microbiology and immunology. 199
Autor:
E. Maraskovsky, N. Fernandez, L. Zitvogel, N. DiFalco, H. Haddada, P. Opolon, M. Perricaudet, L. Cordier
Publikováno v:
Immunology Letters. 56:224